cas 535961-78-5|| where to buy Benzoyl chloride, 2-fluoro-6-methyl- (9CI)

Nom du produit:Benzoyl chloride, 2-fluoro-6-methyl- (9CI)

IUPAC Name:2-fluoro-6-methylbenzoyl chloride

Unité d'emballage	Stock disponible	Prix($)
CM329672-1g	1-2 Weeks	ȯŪ
CM329672-5g	3-4 Weeks	ȖŪȯ
CM329672-25g	4-5 Weeks	ƃǫǫ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 535961-78-5 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:535961-78-5; Formule moléculaire:C8H6ClFO; Point de fusion:-; Code SMILES:O=C(Cl)C1=C(C)C=CC=C1F; Densité:

: Numéro de catalogue:CM329672; Poids moléculaire:172.58; Point d'ébullition:; N° Mdl:; Stockage:

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

: Zegocractin; CalciMedica announces positive topline data from phase 2b CARPO trial of Auxora™ in Acute Pancreatitis (AP). The trial met primary objective with statistically significant dose response. Calcium release–activated calcium (CRAC) channels are involved in activating T cells, and responsible for regulating calcium-dependent inflammatory pathways or tissue cell injury pathways. AP is a potentially life-threatening inflammatory disease of the pancreas featured by aberrant signaling of calcium.
CalciMedica’s Auxora is a potent and selective intravenous formulated CRAC channel inhibitor containing the active ingredient Zegocractin. It is being developed for the treatment of acute inflammatory and immunologic illnesses, including severe AP, AIPT, AKI, and severe acute respiratory diseases including AHRF, and ARDS.